In a recent WMUR segment hosted by Fred Kocher, Andrea Hechavarria, President and CEO of New Hampshire Life Sciences, and Ryan Holder, Senior Director of Operations at Lonza, discussed the rapid growth of New Hampshire’s life sciences sector. They highlighted how the industry, driven by over 600 businesses, is becoming a major economic force in the state.

Lonza Portsmouth has become the fifth founding member of NH Life Sciences, joining industry leaders to boost New Hampshire’s growing life sciences sector. The company specializes in the production of biopharmaceuticals and cell therapies. To further highlight this growth, NHLS will host its inaugural event on Oct. 9 at Salem’s Tuscan Village, showcasing the area as a prime location for life sciences companies.

Novo Nordisk welcomed New Hampshire Governor Chris Sununu on a tour of their Active Pharmaceutical Ingredients (API) manufacturing site in West Lebanon to learn more about the company’s workforce expansion at the site that produces medicines for patients around the world with chronic disease.

NH's life sciences industry may not always receive the attention it deserves, but recent developments in the Manchester Millyard's biofabrication cluster highlight its significance. With a generous $44 million Build Back Better Regional Challenge Grant awarded in November 2022, efforts are underway to create a dedicated hub for biofabrication in the area.

MilliporeSigma is the latest founding member to join the New Hampshire Life Sciences nonprofit trade association. Alongside esteemed companies such as Novocure, Novo Nordisk, and Timberline Construction, MilliporeSigma reinforces the innovative climate in the Granite State.

Timberline Construction Corp. has joined New Hampshire Life Sciences as the trade group’s third founding member. Timberline will join Novocure and Novo Nordisk in launching NHLS, the first statewide life-sciences association built for the industry.

New Hampshire Life Sciences (NHLS), a newly formed trade group that supports the Granite State’s life sciences industry, has signed two companies that employ hundreds of workers as its inaugural founding members: Novocure and Novo Nordisk.

Throughout 2023, the life sciences industry has been faced with many operational issues, including supply-chain uncertainty, inflation, and talent shortages. Read NH’s feature on biopharmareporter.com.

The New Hampshire Department of Business and Economic Affairs (BEA) today announced the findings of a statewide life sciences industry assessment, which found that the state’s life science workforce added 1,484 jobs, representing a 15.1% growth rate within the industry and 3.8% of the state’s total job growth between 2012 and 2021.